Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
Human EDTA-treated whole blood samples were stained with CD16 antibodies using a lyse-wash procedure and analyzed by flow cytometry using the MACSQuant ® Analyzer. For analysis, white blood cells were gated based on forward and side scatter signals and after exclusion of cell debris and red blood cells based on scatter signals and CD45 fluorescence. |
Figure 1Human EDTA-treated whole blood samples were stained with CD16 antibodies using a lyse-wash procedure and analyzed by flow cytometry using the MACSQuant ® Analyzer. For analysis, white blood cells were gated based on forward and side scatter signals and after exclusion of cell debris and red blood cells based on scatter signals and CD45 fluorescence. | Figure 1Human EDTA-treated whole blood samples were stained with CD16 antibodies using a lyse-wash procedure and analyzed by flow cytometry using the MACSQuant ® Analyzer. For analysis, white blood cells were gated based on forward and side scatter signals and after exclusion of cell debris and red blood cells based on scatter signals and CD45 fluorescence. | Figure 1Human EDTA-treated whole blood samples were stained with CD16 antibodies using a lyse-wash procedure and analyzed by flow cytometry using the MACSQuant ® Analyzer. For analysis, white blood cells were gated based on forward and side scatter signals and after exclusion of cell debris and red blood cells based on scatter signals and CD45 fluorescence. |
Clone | REA423 |
---|---|
Isotype | recombinant human IgG1 |
Type of antibody | Recombinant antibodies |
Species | human |
Antigen | CD16 |
Alternative names of antigen | FCGR3A, FCGR3B, FcR-10, IGFR3, IMD20, FcRII |
Molecular mass of antigen [kDa] | 48 |
Distribution of antigen | NK cells, monocytes, granulocytes, dendritic cells, macrophages, mast cells, neutrophils |
Human EDTA-treated whole blood samples were stained with CD16 antibodies using a lyse-wash procedure and analyzed by flow cytometry using the MACSQuant ® Analyzer. For analysis, white blood cells were gated based on forward and side scatter signals and after exclusion of cell debris and red blood cells based on scatter signals and CD45 fluorescence. |
Figure 1Human EDTA-treated whole blood samples were stained with CD16 antibodies using a lyse-wash procedure and analyzed by flow cytometry using the MACSQuant ® Analyzer. For analysis, white blood cells were gated based on forward and side scatter signals and after exclusion of cell debris and red blood cells based on scatter signals and CD45 fluorescence. | Figure 1Human EDTA-treated whole blood samples were stained with CD16 antibodies using a lyse-wash procedure and analyzed by flow cytometry using the MACSQuant ® Analyzer. For analysis, white blood cells were gated based on forward and side scatter signals and after exclusion of cell debris and red blood cells based on scatter signals and CD45 fluorescence. | Figure 1Human EDTA-treated whole blood samples were stained with CD16 antibodies using a lyse-wash procedure and analyzed by flow cytometry using the MACSQuant ® Analyzer. For analysis, white blood cells were gated based on forward and side scatter signals and after exclusion of cell debris and red blood cells based on scatter signals and CD45 fluorescence. |
Clone | REA423 |
---|---|
Isotype | recombinant human IgG1 |
Type of antibody | Recombinant antibodies |
Species | human |
Antigen | CD16 |
Alternative names of antigen | FCGR3A, FCGR3B, FcR-10, IGFR3, IMD20, FcRII |
Molecular mass of antigen [kDa] | 48 |
Distribution of antigen | NK cells, monocytes, granulocytes, dendritic cells, macrophages, mast cells, neutrophils |
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.